Alabama Academy of Family Physicians
MAY 15, 2025
The 2025 Alabama Legislative Session concluded on May 14 at midnight. To incentivize donations to these hospitals, the bill suggests creating a tax credit for individuals and entities to offset their state income tax liability. What Happened: The bill was signed into law by the Governor on 4/15/2025.
Minnesota Academy of Family Physicians
MARCH 27, 2025
SENATE HEALTH AND HUMAN SERVICES (HHS) COMMITTEE On Tuesday, March 18, 2025, the Senate HHS Committee heard a series of health care bills: S.F. The Minnesota Hospital Association, as well as some individual hospitals, testified in support of the bill. Listing circumstances under which an individual health plan cannot be renewed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
My Green Doctor
MAY 3, 2025
operating rooms is regulated by the individual states; changing to multi-dose eyedrops will require administrative and legislative advocacy by eye specialists in every state and country. The product manufacturers and vendors will need to be active partners as well. The use of medications in U.S.
Physician's Weekly
JUNE 18, 2025
Cost-sharing interventions and patient education can help improve access to GLP-1 receptor agonists for patients with obesity, according to an abstract presented at the AACE Annual Meeting 2025.
FDA Law Blog
JANUARY 16, 2025
Hyman, Phelps & McNamara PC, (HPM), which will mark its 45thAnniversary on March 17, 2025, is pleased to announce that it is increasing its directors, counsel, and associates as it starts the year. Richardson has been promoted to Director.
FDA Law Blog
JANUARY 2, 2025
The proposed revised rule constituted a radical change from the original definition of healthy, which focused on the presence of individual (beneficial) nutrients. In contrast, the 2022 proposed redefinition focused on food groups recommended by nutrition science and the Dietary Guidelines (DGs), 2020-2025.
FDA Law Blog
JANUARY 5, 2025
In either case, if the consumer wrongly enters their information, e.g., and as a result obtains a drug that had they entered the information correctly, they would not have received, does that make the drug misbranded and the drug manufacturer responsible for distributing a misbranded drug? Further elaboration of FDAs view would be helpful.
Expert insights. Personalized for you.
130 
Let's personalize your content